Global Radiotherapy Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Global Radiotherapy Market According to Data Bridge Market Research new Market report, “By Type (Beam Radiotherapy {IGRT, IMRT, VMAT, Tomotherapy, Stereotactic Technology, 3D Conformal Technology}, Brachytherapy {LDR, HDR}, Systemic Radiotherapy), By Product Type (External Beam Radiotherapy{LINAC, Cyber Knife, Proton Beam Therapy {Cyclotron, Synclotron}, Gamma Knife}, Internal Radiotherapy Products {Seeds, After loaders}, Radiotherapy Software {Treatment Planning Software, Dosage Planning Software, Patient Positioning Software, Image Guiding Software}, Systematic Radiotherapy), By Indications (Prostate Cancer, Breast Cancer, Lung Cancer, Spine Cancer, Liver Cancer, Brain Cancer, Others),  By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast is projected to reach USD 10.48 billion by 2025, at a CAGR of 8.1% during the forecast period of 2018 to 2025.

Access Full Report: https://databridgemarketresearch.com/reports/global-radiotherapy-market/

Global Radiotherapy Market

Radiotherapy also known as radiation therapy is the treatment of cancer which uses high energy radiation to kill cancer tissues in the body. This therapy stops cancer cells from multiplying in the body.. According to national center for biotechnology information, more than 14 million new cases of cancer are diagnosed each year and radiation therapy has a potential to improve the rates of cure for about  3.5 million people along with  providing  relief to additional 3.5 million people.

According to the research published in the journal of medical imaging and radiation oncology, the most effective treatment for prostate cancer is external-beam radiation therapy. Men with prostate cancer who are treated with external-beam radiation therapy have cure rate of 95.5% for intermediate risk prostate cancer and 91.3% for high risk prostate cancer.  It was found that the patient treated with modern external-beam radiation therapy has 98.8% free survival rate for 5 years.

A  study was conducted on 715 women who were suffering from stage 1uterine cancer  by Texas oncology, to observe the  difference in  treatment with surgery alone and treatment with surgery followed by adjuvant external beam radiation therapy.  It was found that the cancer recurrence rate was 4.0% and the survival rate was 81.0% in the patients treated with surgery followed by adjuvant external beam radiation therapy and the cancer recurrence rate was 14.0% and the survival rate was 85.0% in the patients who were treated with surgery alone. The survival rate was higher in treatment by surgery alone because the radiation had various side effects on women.

In Florida a study was conducted on 396 women who were suffering from stage 1 uterine cancer treated with hysterectomy, lymph node dissection and brachytherapy. From the study it was observed that the 5 years survival rate was 100.0% for cancer confined to the inner layer of cells of the uterus, 97.0% for the patients with  cancer that invades less than one half of the muscle wall of the uterus and 93.0% for the patients with cancer that invades more than one half of the muscle wall of the uterus .  

Segmentation: Global Radiotherapy Market

The global market for radiotherapy by the following sub-categories is presented

  • By Type
    • Beam Radiotherapy
      • IGRT
      • IMRT
      • VMAT
      • Tomotherapy
      • Stereotactic Technology
      • 3D Conformal Technology
    • Brachytherapy
      • LDR
      • HDR
    • Systemic Radiotherapy
  • By Product Type
    • External Beam Radiotherapy
      • LINAC
      • Cyber Knife
      • Proton Beam Therapy
        • Cyclotron
        • Synclotron
      • Gamma Knife
    • Internal Radiotherapy Products
      • Seeds
      • After loaders
    • Radiotherapy Software
      • Treatment Planning Software
      • Dosage Planning Software
      • Patient Positioning Software
      • Image Guiding Software
    • Systematic Radiotherapy
  • By Indications
    • Prostate Cancer
    • Breast Cancer
    • Lung Cancer
    • Spine Cancer
    • Liver Cancer
    • Brain Cancer
    • Others
  • By Geography
    • North America
    • South America
    • Europe
    • Asia-Pacific
    • Middle East and Africa

FACTORS DRIVING GROWTH IN GLOBAL RADIOTHERAPY MARKET

Rising incidence of cancer:

According to American cancer society, prostate cancer is the most common type of cancer in the American men. As per 2018 data, about 164,690 new cases of prostate cancer were diagnosed. It was observed that about 29,430 deaths occurred due to prostate cancer. According to the national institute of cancer and prevention, one woman dies every 8 minutes in India because of cervical cancer. and out of  2 women diagnosed newly with breast cancer,1 women dies out of it in India. 2500 people die every day in India due to tobacco related diseases. Estimated number of people living with cancer in India is 2.5 million. Around 7 lakh of new cancer cases are registered in India every year. 71% of all the cancer deaths occur among the age group of 30-60 years. Cervical cancer is the second most common cancer in India accounting for about 22.86% of all cancer cases and breast cancer accounts for 27% of all cancer cases amongst women in India.

According to the national cancer institute, in 2018 an estimated 1,735,350 new cases of cancer will be diagnosed in United States and 609,640 people will die of it. The number of new cases of cancer  in men and women combined were 439.2 per 100,000 based on 2011-2015 cases. In 2016 there were 15.5 million cancer survivors in United States and this is expected to increase to 20.3 million by 2026. The national cancer care expenditure for U.S. in the year 2017 was 147.3 billion USD and this is expected to increase due to growing population and growing prevalence of cancer.

According to national central cancer registry of China, there were 42, 92,000 new cases of cancer and 28, 14,000 cancer deaths in China in the year 2015 representing around 6.5% of the total population of china. A study was conducted in Europe by world health organization in the year 2012 and it was found that there are 3.7 million new cases of cancer every year and 1.9 million deaths occur each year in Europe because of cancer. Europe comprises only one eighth of the total world population but has one quarter of total cancer cases meaning that cancer accounts for 20.0% of the deaths in Europe.

According to the stats provided above, it is observed that the cases of cancer are increasing with higher growth rates, which in future needs to be treated using beam radiotherapy or brachytherapy. Hence, this market is expected to get a very strong platform in future.

Increasing number of cancer treatment facilities:

According to the national cancer institute (NCI), NCI is one of the major part of nation’s cancer research effort. There are around 70 NCI designated cancer centers located in 36 states and districts of Columbia.. Approximately 250,000 patients received cancer diagnosis at NCI designated cancer center in 2017. According to the national institute of cancer prevention and research, Government of India has recognized around 27 cancer centers under the national cancer control programme in 2010 in around 21 states.

According to world health organization, the global cancer rates are expected to increase by 50% to 15 million new cases in the year 2020. Hence with this increasing cancer rate, the government has to establish new cancer treatment facilities in order to decrease the death rate and increase the cure rate. Hence, this market is expected to grow in future.

Major market players in global radiotherapy market are Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, CIVCO Medical Solutions, Brainlab, C. R. Bard Inc, IsoRay Inc., Nordion Inc , Raysearch laboratories, EASEE, Mevion Medical Systems, Hitachi Ltd, Sumitomo Heavy Industries, Ltd, Mitsubishi Electric Corporation,  TOSHIBA CORPORATION, Provision Healthcare,  ProTom International, IBA Worldwide.

Browse Related Reports:      

Global Infusion Pump Systems, Accessories and Software Market, By Type (Infusion Pump Systems, Infusion Pump Accessories, Infusion Pump Management Software, Application (General Infusion, Pain and Anesthesia Management, Insulin Infusion, Enteral Infusion, Chemotherapy), End-User, Geography – Trends and Forecast to 2024.

http://databridgemarketresearch.com/reports/infusion-pump-market-accessories-software-market/

Global Active Pharmaceutical Ingredients (API) Market, By ProductType (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone), Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024.

http://databridgemarketresearch.com/reports/global-active-pharmaceutical-ingredient-api-market/

North America Diabetes Care Devices Market By Product Type, By End-User, By Distribution Channel, By Country (U.S., Canada, Mexico)- Industry Trends and Forecast to 2024.

http://databridgemarketresearch.com/reports/north-america-diabetes-care-devices-market/

North America Fetal Bovine Serum Market, By Product Type, By End-Users, By Distribution Channel, By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024.

http://databridgemarketresearch.com/reports/north-america-fetal-bovine-serum-market/

Choose License Type
  • 200
  • 300
BUY NOW ADD TO CART